NHS to offer epilepsy patients brain laser therapy
The launch of the laser is part of the NHS’s Long Term Plan commitment
Read More
Author: Fleur Jeffries
ICR scientists study cancer response to new class of drugs
The research could help determine drug responses through genetic testing
Read More
Kite and Refuge Biotechnologies to work together to research blood cancer
The licence agreement bolsters Kite’s expertise in synthetic biology for oncology
Read More
ICR’s new study tracks disease progression in children with rare type of cancer
Researchers assessed whether measuring DNA shed by cancer cells into the bloodstream could track tumour progression
Read More
canSERV rolls out cancer research services across Europe
European wide research infrastructures, oncology experts and patient associations link up to combat cancer
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
